Roger E. Susi - 05 Jan 2026 Form 4 Insider Report for IRADIMED CORP (IRMD)

Signature
/s/ Roger E. Susi
Issuer symbol
IRMD
Transactions as of
05 Jan 2026
Net transactions value
-$488,417
Form type
4
Filing time
06 Jan 2026, 16:05:05 UTC
Previous filing
30 Dec 2025
Next filing
13 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Susi Roger E. CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner C/O IRADIMED CORPORATION, 12705 INGENUITY DRIVE, ORLANDO /s/ Roger E. Susi 06 Jan 2026 0001613801

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Sale $81,215 -854 -0.04% $95.10 2,281,646 05 Jan 2026 By Phillip Susi 2008 Dynasty Trust F1, F2
transaction IRMD Common Stock Sale $28,674 -300 -0.01% $95.58 2,281,346 05 Jan 2026 By Phillip Susi 2008 Dynasty Trust F1
transaction IRMD Common Stock Sale $86,110 -883 -0.04% $97.52 2,280,463 05 Jan 2026 By Phillip Susi 2008 Dynasty Trust F1, F3
transaction IRMD Common Stock Sale $217,410 -2,209 -0.1% $98.42 2,278,254 05 Jan 2026 By Phillip Susi 2008 Dynasty Trust F1, F4
transaction IRMD Common Stock Sale $75,008 -754 -0.03% $99.48 2,277,500 05 Jan 2026 By Phillip Susi 2008 Dynasty Trust F1, F5
holding IRMD Common Stock 162,950 05 Jan 2026 By Roger E. Susi Revocable Trust
holding IRMD Common Stock 2,062,500 05 Jan 2026 By Matthew Susi 2008 Dynasty Trust F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.
F2 This transaction was executed in multiple trades at prices ranging from $94.55 to $95.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $97.09 to $98.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $98.12 to $98.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $99.41 to $99.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.